(Q51305744)

3 April 2018

title

Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy. (English)

1 reference

3 April 2018

1 reference

Wenchao Hu

1

1 reference

3 April 2018

Rui Wang

2

1 reference

3 April 2018

Jun Li

3

1 reference

3 April 2018

Jie Zhang

4

1 reference

3 April 2018

Wenhui Wang

5

1 reference

3 April 2018

publication date

26 March 2015

1 reference

3 April 2018

Annals of Clinical Biochemistry

published in

1 reference

3 April 2018

volume

53

1 reference

3 April 2018

issue

Pt 1

1 reference

3 April 2018

page(s)

67-74

1 reference

3 April 2018

Standards of medical care in diabetes--2010.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Diabetic retinopathy and systemic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Relationship between circulating irisin, renal function and body composition in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Lower circulating irisin is associated with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Serum irisin levels in new-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Decrease in irisin in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Serum levels of the myokine irisin in relation to metabolic and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Inflammation in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Irisin in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004563215582072

21 January 2018

Identifiers

DOI

10.1177/0004563215582072

1 reference

3 April 2018

1 reference

3 April 2018